Devgen nv and PT (Persero) Sang Hyang Seri obtain registration
approval of two hybrid rice varieties
(Thomson Reuters ONE) - Ghent - Jakarta, October 13, 2009. Devgen nv (EURONEXT, Brussels:DEVG) and PT (Persero) Sang Hyang Seri (SHS) today announce that 2premium hybrid rice varieties, DG 1 SHS and DG 2 SHS have beengranted registration for commercial sale in Indonesia.This result follows large scale trials of Devgen's pipeline of ricehybrids in 10 locations across Indonesia. As part of the Devgen - PT(Persero) Sang Hyang Seri research cooperation, these products havebeen extensively evaluated a.o. for yield, disease resistance andgrain quality, all critical parameters for the Indonesian farmer.Hybrid seed varieties DG 1 SHS and DG 2 SHS were approved by theIndonesian Ministry of Agriculture in accordance with its stringentstandards for new rice hybrid varieties. The hybrid seeds will bedistributed in Indonesia by PT (Persero) Sang Hyang Seri underDevgen's brand name Frontline. Product launch and first sales aretargeted as planned for late Q4 09/Q1 2010."The availability of hybrid rice products that are well adapted tothe local environment, that meet farmers' needs while providing agood value proposition is a prerequisite to the effectiveintroduction of hybrid rice in Indonesia" says Devgen's CEO, ThierryBogaert "We are confident that DG 1 SHS, DG 2 SHS and other productsin our pipeline will mark a turning point for hybrid rice inIndonesia.""We are proud to have developed and registered these productstogether with Devgen." says PT (Persero) Sang Hyang Seri's PresidentDirector, Mr. Eddy Budiono "As per government guidance, we arecommitted to provide the Indonesian farmer with hybrid rice productsthat increase yield and productivity. These hybrid seeds are amongstthe best in the world. We will scale up the production to fulfillIndonesia and export markets so that the world food supply isincreased as a result of using these high productivity seeds-whichalso produce good taste rice"About PT (Persero) Sang Hyang SeriPT (Persero) Sang Hyang Seri is a government wholly owned companydealing with seed, fertilizer and agrochemicals with offices andfarms across Indonesia.About Devgen nvDevgen's mission is to enable farmers to sustainably grow more foodon less land, with less water, agrochemicals and labour.Devgen uses advanced biotechnology and molecular breeding technologyto make high yielding seeds and crop protection solutions with asuperior environmental profile.Devgen brings this technology to the market in the world's major foodand feed crops through two complementary strategies:- Licensing Devgen technology for use in corn, cotton and soy andselected other crops in exchange for R&D funding, and milestone androyalty payments.- Producing and selling its premium hybrid seeds in major fieldcrops such as rice, sunflower, sorghum, and pearl millet, in theIndian subcontinent and South-East Asia.In its Crop Protection unit, Devgen developed and has taken to marketa novel nematicide, an agro-chemical product that protects crops fromdamage by parasitic nematodes.Incorporated in 1997, Devgen has offices in Ghent (Belgium),Singapore, Hyderabad (India) and Delaware (US) and employs more than200 people.For more information please contact:Thierry Bogaert, CEO Wim Goemaere, CFOTel. +32 9 324 24 24 Tel. +32 9 324 24 24Thierry.Bogaert(at)devgen.com Wim.Goemaere(at)devgen.comOr visit: www.devgen.comThis press release may contain forward-looking statements containingthe words "anticipates", "expects" , "intends", "plans", "estimates","may" and "continues" as well as similar expressions. Such forwardlooking statements may involve known and unknown risks, uncertaintiesand other factors which might cause the actual results, performanceor achievements of Devgen to be materially different from any futureresults or achievements expressed or implied by such forward-lookingstatements. Factors that could cause or contribute to suchdifferences include, among others: agricultural risks anddifficulties, including weather factors, diseases and pests, thecosts and requirements of regulatory compliance and the speed withwhich approvals are received; public acceptance of biotechnologyproducts; political, economic and social developments in countrieswhere Devgen operates and other risks and factors detailed in thecompany's most recent annual report.These forward looking statements speak only as of the date ofpublication of this document. Devgen disclaims any obligation toupdate such forward looking statements in this document to reflectany change in its expectations, conditions or circumstances on whichsuch statement is based, unless required by law or regulation. Thisdocument does not constitute, or form part of, any offer orinvitation to sell or issue, or any solicitation of any offer, topurchase or subscribe for any securities issued by Devgen NV.http://hugin.info/135721/R/1347082/323785.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 13.10.2009 - 08:16 Uhr
Sprache: Deutsch
News-ID 6836
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 280 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Devgen nv and PT (Persero) Sang Hyang Seri obtain registration
approval of two hybrid rice varieties"
steht unter der journalistisch-redaktionellen Verantwortung von
Devgen (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
